The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo

Yang Can; Gong Yu Hang; Wang Hai Feng; Li Hai Hao; Liu Jing Yu; Wang Wei; Wang Jian Song; Zuo Yi Gang; Chen Jian; Zhan Hui; Ding Ming Xia

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(05): 1-6

Yang Can , Gong Yu Hang , Wang Hai Feng , Li Hai Hao , Liu Jing Yu , Wang Wei , Wang Jian Song , Zuo Yi Gang , Chen Jian , Zhan Hui , Ding Ming Xia . The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo[J]. Journal of Kunming Medical University, 2018, 39(05): 1-6.

Citation:

Yang Can , Gong Yu Hang , Wang Hai Feng , Li Hai Hao , Liu Jing Yu , Wang Wei , Wang Jian Song , Zuo Yi Gang , Chen Jian , Zhan Hui , Ding Ming Xia . The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo[J]. Journal of Kunming Medical University, 2018, 39(05): 1-6.

Citation:

Yang Can , Gong Yu Hang , Wang Hai Feng , Li Hai Hao , Liu Jing Yu , Wang Wei , Wang Jian Song , Zuo Yi Gang , Chen Jian , Zhan Hui , Ding Ming Xia . The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo[J]. Journal of Kunming Medical University, 2018, 39(05): 1-6.

PDF( 2816 KB)

The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo

Funds:

基金：国家自然科学基金资助项目 (81360376);

Received Date: 2017-09-20

Abstract

Abstract

Objective To research the monoclonal antibody KMP1 inhibited bladder cancer EJ cell lines growth and metastasis in vivo by bioluminescence imaging. Me thods Immunohistochemistry was used to determine the KMP1 binding to EJ and EJ-GFP cell lines. The xenograft tumor cell growth and distribution were measured by vernier calipers and dynamic in vivo fluorescence imaging. Immunohistochemistry and H&E counterstaining researched the feature of the xenograft tumor. Re s ults Cell growth curves of EJ and EJ-GFP cells were similar.EJ-GFP had a green fluorescence. In EJ-GFP nude mouse tumor model, the addition of KMP1 significantly inhibited tumor growth and extended the average life span of nude mice. Both EJ and EJ-GFP cells can bind to KMP1, and the weight of transplanted tumors in the KMP1 treatment group was significantly lower than that of the m Ig G control group (P <0.001) .Conclus ion KMP1 has a promising antitumor effect in vivo. It might be valuable for development as a promising targeted agent for bladder cancer.
- Bladder carcinoma,
- EJ cells,
- Monoclonal antibody

FullText(HTML)

References(14)

References

[1]丁明霞, 李翀, 左毅刚, 等.膀胱癌EJ细胞的CD44异常糖基化及其单抗KMP1的生物学功能研究[J].中国肿瘤临床, 2011, 38 (13) :759-762.
[2]	[2]TORRE L A, BRAY F, SIEGEL R L, et al.Global cancer statistics[J].Cancer Journal for Clinicians, 2015, 65 (2) :87-108.
[3]	[3] FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al.Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].International Journal of Cancer Journal International Ducancer, 2015, 136 (5) :E359-386.
[4]	[4]CHEN W, ZHENG R, ZENG H, et al.Annual report on status of cancer in China, 2011[J].Chinese Journal of Cancer Research, 2015, 27 (1) :2-12.
[5]李绍林, 修有成, 刘赞.肌层浸润型膀胱癌治疗的研究进展[J].医学综述, 2018, 24 (5) :911-915.
[6]	[6] SHAH J B, MCCONKEY D J, DINNEY C P.New strategies in muscle-invasive bladder cancer:on the road to personalized medicine[J].Clinical Cancer Research:an Official Journal of the American Association for Cancer Research, 2011, 17 (9) :2608-2612.
[7]	[7]LIGHTFOOT A J, BREYER B N, ROSEVEAR H M, et al.Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer[J].Urol Oncol, 2014, 32 (1) :35.e15-35.e19.
[8]	[8]NEPPLE K G, LIGHTFOOT A J, ROSEVEAR H M, et al.Bacillus Calmette-Guerin with or without interferon alpha-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer[J].J Urol, 2010, 184 (5) :1915-1919.
[9]	[9] POWLES T, EDER J P, FINE G D, et al.MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer[J].Nature, 2014, 515 (7528) :558-562.
[10]	[10] PETRYLAK D P, POWLES T, BELLMUNT J, et al.A phase la study of atezolizumab (MPDL-3280A) :updated response and survival data in urothelial bladdercancer (UBC) [J].J Clin Oncol, 2015, 33 (Suppl) ::4501.
[11]丁明霞, 李翀, 左毅刚, 等.CD44 RNAi对EJ细胞增殖、迁移及其与特异性单抗结合力的影响[J].基础医学与临床, 2012, 32 (3) :313-316.
[12]丁明霞, 李翀, 左毅刚, 等.人膀胱癌EJ细胞株CD44基因的小RNA干扰抑制细胞侵袭功能[J].现代泌尿生殖肿瘤杂志, 2012, 3 (6) :345-347.
[13]	[13] DING M X, WANG H F, WANG J S, et al.pp Gal NAc T1as a potential novel marker for human bladder cancer.Asian Pac[J].J Cancer Prev, 2012, 13 (11) :5653-5657.
[14]	[14] BROOKS C L, SCHIETINGER A, BORISOVA SN, et al.Antibody recognition of a unique tumor-specific glycopeptide antigen[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (22) :10056-10061.

Relative Articles(20)

Relative Articles

[1]	Sheng LIU, Fei YUAN, Hongqing ZHOU, Mingsheng LIU, Donghuan ZOU, Yu LI, Zihan DAI, Guanyu CHEN, Feng GUO. Analysis of the Efficacy of Complete Pelvic Floor Peritoneal Reconstruction Technique in Total Cystectomy with Orthotopic Neobladder. Journal of Kunming Medical University, 2024, 46(): 1-7.
[2]	Yuqin LIU, Mingying YANG, Liufang WANG, Siya XIA, Danna LI, Xijuan ZHAO, Ya WANG. Development of a Patient-reported Outcome Scale For Bladder Cancer and Test of Reliability and Validity. Journal of Kunming Medical University, 2024, 45(7): 183-190. doi: 10.12259/j.issn.2095-610X.S20240727
[3]	Yijun AN, Lidan YU, Meisu ZHAO, Dongmei MA, Chunhua YANG, Yao KONG. The Application of Prognostic Model of Lysosomal Related Genes in Bladder Cancer. Journal of Kunming Medical University, 2024, 45(5): 66-72. doi: 10.12259/j.issn.2095-610X.S20240510
[4]	Yuqing XIE, Jun WANG, Xuebi JI, Ping WANG, Haifeng WANG, Xumin LI, Linya HUANG. Research Progress on Risk Factors and Risk Assessment of Urinary Tract Infection in Patients with Ureterostomy. Journal of Kunming Medical University, 2023, 44(11): 158-163. doi: 10.12259/j.issn.2095-610X.S20231124
[5]	Jun XIE, Shaoyou LIU, Hongjin SHI, Qiuyu MAO, Hong YANG. Enhanceing Effect of EZH2 Inhibitors in Combination with GC Chemotherapeutic Agents in Bladder Cancer. Journal of Kunming Medical University, 2023, 44(10): 67-76. doi: 10.12259/j.issn.2095-610X.S20231017
[6]	Shi CHEN, Shi FU, Zhiyong TAN, Jiansong WANG, Haifeng WANG. Research Progress of Autophagy in the Development and Treatment of Bladder Cancer. Journal of Kunming Medical University, 2023, 44(5): 168-174. doi: 10.12259/j.issn.2095-610X.S20230503
[7]	Haonan DONG, Haifeng WANG, Yinglong HUANG, Hongjin SHI, Lan MAO, Yijie LIU, Jiansong WANG. A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy. Journal of Kunming Medical University, 2022, 43(12): 159-163. doi: 10.12259/j.issn.2095-610X.S20221229
[8]	Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer. Journal of Kunming Medical University, 2022, 43(1): 150-156. doi: 10.12259/j.issn.2095-610X.S20220110
[9]	Zhi YAN, Jingang HAO, Yunyun SHANG. Value of VI-RADS Scoring System in Precision Treatment of Bladder Cancer. Journal of Kunming Medical University, 2022, 43(3): 74-79. doi: 10.12259/j.issn.2095-610X.S20220322
[10]	Yuan YANG, Hong-min LIANG, Gui-min ZHU, Han-ning YANG, Wei-han CAO, Yong-ping LU. Application of Ultrasound-Targeted Microbubble Destruction with IL-6 Monoclonal Antibody in Rabbit Myocardial Ischemia-Reperfusion Injury. Journal of Kunming Medical University, 2021, 42(2): 6-12. doi: 10.12259/j.issn.2095-610X.S20210222
[11]	Huang Yu , Luan Ting , Wang Hai Feng , Wang Jian Song . . Journal of Kunming Medical University, 2019, 40(11): 147-151.
[12]	Li Dan Na , Yang Ming Ying , Wang Jun , Wang Liu Fang , Wu Guang Liu , Wang Hui Xiao , Chen Jiang Guo , Yao Cheng , Huang Ying Long . . Journal of Kunming Medical University, 2018, 39(09): 27-32.
[13]	Yan Yong , Sun Xuan , Li Gang , Zheng Cuan , Ma Shao Xiang , Li Yong , Zhao Run Heng , Wang Ke . Expression of Survivin in Circulating Tumor Cells in Patients with Bladder Cancer. Journal of Kunming Medical University, 2017, 38(07): 102-106.
[14]	Lei Yu Ying , Gao Jie , Wang Rao Xiang , Chuan Li Xue , Hao Jin Gang . Value of Diffusion Weighted Imaging in the Diagnosis of Bladder Cancer. Journal of Kunming Medical University, 2017, 38(07): 136-139.
[15]	Hu Xin Yi . Radical Cystectomy and Orthotopic Urinary Diversion with 3D Laparoscopy. Journal of Kunming Medical University,
[16]	Huang Zhen Hua , Shi Xin , Wang Hui Tao , Zhang Jing Song , Wang Guang , Hao Jin Gang , Liu Jian He . Application Value of DWI in Diagnosis of T Staging of Bladder Cancer. Journal of Kunming Medical University, 2016, 37(12): 67-71.
[17]	Wang Hong Ming . . Journal of Kunming Medical University,
[18]	Ma Zhen . . Journal of Kunming Medical University, 2012, 33(07): 1-1.
[19]	. . Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,